Edition:
United States

Aralez Pharmaceuticals Inc (ARZ.TO)

ARZ.TO on Toronto Stock Exchange

5.42CAD
24 Feb 2017
Change (% chg)

$-0.11 (-1.99%)
Prev Close
$5.53
Open
$5.54
Day's High
$5.54
Day's Low
$5.39
Volume
14,428
Avg. Vol
13,300
52-wk High
$8.75
52-wk Low
$4.07

Select another date:

Mon, Jan 9 2017

BRIEF-Aralez provides update on PBM formulary status for Yosprala

* Aralez provides update on PBM formulary status for Yosprala

BRIEF-Aralez pharmaceuticals new post-hoc analysis supports yosprala efficacy

* Aralez pharmaceuticals -new post-hoc analysis supports yosprala efficacy and safety in previous heart attack patients who need daily aspirin therapy Source text for Eikon: Further company coverage:

U.S. approves Aralez pill for heart patients; stock jumps

The U.S. Food and Drug Administration on Thursday approved a pill that combines aspirin and the acid-fighting drug omeprazole to guard against gastric ulcers in patients who require daily aspirin.

U.S. approves Aralez pill for heart patients; stock jumps

Sept 15 The U.S. Food and Drug Administration on Thursday approved a pill that combines aspirin and the acid-fighting drug omeprazole to guard against gastric ulcers in patients who require daily aspirin.

BRIEF-Aralez announces FDA approval of Yosprala for secondary prevention of cardiovascular and cerebrovascular events in patients at risk for aspirin-associated gastric ulcers

* Announces FDA approval of YOSPRALA for secondary prevention of cardiovascular and cerebrovascular events in patients at risk for aspirin associated gastric ulcers

BRIEF-Aralez acquires U.S., Canadian rights to Zontivity from Merck

* Aralez acquires united states and canadian rights to Zontivity from Merck

Select another date:

More From Around the Web